Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 2, 1999, Pages 161-166

  Rich, Josiah D ^a   Dickinson, Brian P ^a   Macalino, Grace ^b   Flanigan, Timothy P ^a   Towe, Christopher W ^a   Spaulding, Anne ^c   Vlahov, David ^b  

^a MIRIAM HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RHODE ISLAND DEPARTMENT OF CORRECTIONS   (United States)

Author keywords

AIDS serodiagnosis; HIV seropositivity; HIV seroprevalence; HIV 1; Incidence; Mandatory testing; Mass screening; Prisoners; Prostitution; Rhode Island; Risk factors; Sex behavior; Sexually transmitted diseases; Substance abuse, intravenous

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL; PRISONER; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; SEXUAL BEHAVIOR; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032708129     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199910010-00008     Document Type: Article

References (35)

1. [U.S.] National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through December 1997. HIV/AIDS Surveill Rep 1997;9: 1-43.
2. AIDS associated with injecting-drug use in the United States 1995. MMWR Morb Mortal Wkly Rep 1996;9:392-8.
3. Wortley PM, Fleming PL. AIDS in women in the United States. Recent Trends. JAMA 1997;278:911-16.
4. Weiner J, Anno J, for the American College of Physicians Human Rights and Medical Practice Subcommittee for the Health and Public Policy Committee. Position paper: the crisis in correctional health care: the impact of the national drug control strategy on correctional health services. Ann Intern Med 1992;117:71-7.
5. Dixon PS, Flanigan TP, DeBuono BA, et al. Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med 1993;95:629-35.
6. Gaiter J. Improving HIV/AIDS prevention in prisons is good public health policy [editorial]. Am J Public Health 1996;86:1201-3.
7. Berkman A. Prison health: the breaking point. Am J Public Health 1995;85:1616-18.
8. Beck A, Gilliard D, Greenfeld L, et al. Office of Justice Programs, U.S. Department of Justice survey of state prison inmates, 1991. Washington, DC: U.S. Government Printing Office, 1992.
9. Mumola CJ, Beck AJ. Office of Justice Programs, U.S. Department of Justice, prisoners in 1996 [NCJ 164619]. Bureau of Justice Statistics bulletin. Washington, DC: U.S. Government Printing Office, 1997:1-5.
10. Hammett TM, Widom R, Epstein J, et al. Office of Justice Programs, U.S. Department of Justice, issues and practices, 1994 update: HIV/AIDS and STDs in correctional facilities [NCJ 156832]. Washington, DC: U.S. Government Printing Office, 1995:1-87.
11. Maruschnak L. HIV in prisons and jails, 1995 [NCJ-164260]. Bureau of Justice Statistics bulletin, Office of Justice Programs, U.S. Department of Justice. Washington, DC: U.S. Government Printing Office, 1997:1-11.
12. Hankins CA, Gendron S, Handley MA, Richard C, Lai Tung MT, O'Shaughnessy M. HIV infection among women in prison: an assessment of risk factors using non-nominal methodology. Am J Public Health 1994;84:1637-40.
13. Vlahov D, Brewer F, Munoz A, Hall D, Taylor E, Polk BF. Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. J Acquir Immune Defic Syndr 1989;2:283-90.
14. Weisfuse IB, Greenberg BL, Back SD, et al. HIV-1 infection among New York inmates. AIDS 1991;5:1133-8.
15. Vlahov D, Brewer TF, Castro KG, et al. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265:1129-32.
16. Mahon N. New York Inmates' HIV risk behaviors: the implications for prevention policy and programs. Am J Public Health 1996;8:1211-15.
17. Beck AJ, Gilliard D, Greenfeld L, et al. Office of Justice Programs, U.S. Department of Justice, prisoners in 1991 [NCJ 136949]. Bureau of Justice Statistics. Washington, DC: U.S. Government Printing Office, 1993.
18. Brien PM, Beck AJ. HIV in prisons 1994 [NCJ 158020]. Bureau of Justice Statistics Bulletin, Office of Justice Programs, U.S. Department of Justice. Washington, DC: U.S. Government Printing Office, 1996:1-8.
19. Flanigan TP. HIV testing in prison. Lancet 1995;345:390.
20. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: U.S. Centers for Disease Control and Prevention, 1995.
21. StataCorp. Stata statistical software, release 5.0. College Station, TX: Stata Corporation, 1997.
22. Werner B, Eastman E, Gagnon T, Demaria A, Timperi R. Drop in HIV seroprevalence rates among men and women entering MA prisons [abstract 115]. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1995.
23. Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991-1996. Am J Public Health 1998;88:1801-6.
24. Torian LV, Makki HA, Weisfuse IB. Changes in HIV seroprevalence in entrants to the New York City correctional system [abstract 142]. Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, 1998.
25. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146:459-69.
26. Gellert GA, Maxwell RM, Higgins KA, Pendergast T, Wilker N. HIV infection in the women's jail, Orange County, California, 1985 through 1991. Am J Public Health 1993;83:1454-6.
27. Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med 1995;155:1305-11.
28. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996;348:987-91.
29. Flanigan TP, Kim JY, Zierler S, Rich J, Vigilante K, Bury-Maynard D. A prison release program for HIV-positive women: linking them to health services and community follow-up [letter]. Am J Public Health 1996;86:886-7.
30. Carpenter CL, Longshore D, Annon K, Annon JJ, Anglin MD. Prevalence of HIV-1 among recent arrestees In Los Angeles County, California: serial cross-sectional study, 1991 to 1995. JAIDS J Acquir Immune Defic Syndr 1999;21:172-7.
31. Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration as a continuing HIV risk factor among injecting drug users in Bangkok [abstract We.D.352]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
32. Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS 1988;2:363-7.
33. Kelley PW, Redfield RR, Ward DL, Burke DS, Miller RN. Prevalence and incidence of HTLV-III infection in a prison. JAMA 1986; 256:2198-9.
34. Castro K, Shansky R, Scardino V, Narkunas J, Coe J, Hammett T. HIV transmission in correctional facilities [abstract M.C.3067]. Presented at the VII International Conference on AIDS, Florence, 1991.
35. Horsburgh CR, Jarvis JQ, McArthur T, et al. Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health 1990;80:209-21.